SEC Form 4 · accession 0001532989-18-000008
Forest City Realty Trust, Inc. · FCEA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles D Obert
Officer — Sr VP, Chief Acct Officer
Period of report
Mar 28, 2018
Accepted (ET)
Mar 29, 2018 · 1:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001647509
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Mar 28, 2018 | F | 1,054 | $20.21 | D | 0 | D | |
| Class A Common StockF2 | holding | — | — | — | 2,627 | D | ||
| Class A Common StockF3 | holding | — | — | — | 3,894 | D | ||
| Class A Common StockF4 | holding | — | — | — | 6,052 | D | ||
| Class A Common StockF5 | holding | — | — | — | 36,808 | D | ||
| Class A Common StockF6 | holding | — | — | — | 760 | I | 401k Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2010 Stock Option Grant (right to buy)F7 | $15.89 | holding | — | — | — | Apr 14, 2012 | Apr 14, 2020 | Class A Common Stock | 4,000 | 0 | D |
| 2011 Stock Option Grant (right to buy)F8 | $17.72 | holding | — | — | — | Apr 13, 2013 | Apr 13, 2021 | Class A Common Stock | 4,000 | 0 | D |
| 2016 Performance SharesF9 | $0.00 | holding | — | — | — | Dec 31, 2018 | Aug 8, 1988 | Class A Common | 5,253 | 5,253 | D |
| 2017 Performance SharesF10 | $0.00 | holding | — | — | — | Dec 31, 2019 | Aug 8, 1988 | Class A Common | 5,191 | 5,191 | D |
| 2018 Performance SharesF11 | $0.00 | holding | — | — | — | Dec 31, 2020 | Aug 8, 1988 | Class A Common | 5,752 | 5,752 | D |
Explanation of responses
- F12014 Restricted Stock Grant - 0% vest on 3/28/2015; 25% vest on 3/28/2016; 25% vest on 3/28/2017; and 50% vest on 3/28/2018.
- F10Performance Shares Award - granted 3/24/2017 - performance period is from January 1, 2017 to December 31, 2019. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $21.83 per share. There is no fixed expiration date.
- F11Performance Shares Award - granted 3/20/2018 - performance period is from January 1, 2018 to December 31, 2020. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $20.89 per share. There is no fixed expiration date.
- F22016 Restricted Stock Grant - 25% vest on 3/23/2017; 25% vest on 3/23/2018; and 50% vest on 3/23/2019.
- F32017 Restricted Stock Grant - 25% vest on 3/24/2018; 25% vest on 3/24/2019; and 50% vest on 3/24/2020.
- F42018 Restricted Stock Grant - 25% vest on 3/24/2019; 25% vest on 3/24/2020; and 50% vest on 3/24/2021.
- F5Shares are held by transfer agent in a direct registration account. 3,470 shares vested on 3/28/2018, of which 1,054 shares were returned to the Company to cover taxes and the balance of the shares were transferred to this account.
- F6FCE's 401k Plan account, shares are held indirect. Updated to reflect current holdings.
- F72010 Stock Option Grant - 25% exercisable 4/14/2012; 25% exercisable 4/14/2013; and 50% exercisable 4/14/2014.
- F82011 Stock Option Grant - 25% exercisable 4/13/2013; 25% exercisable 4/13/2014; and 50% exercisable 4/13/2015.
- F9Performance Shares Award - granted 3/23/2016 - performance period is from January 1, 2016 to December 31, 2018. Awards will be available to the grantee at the end of the performance period provided that certain performance criteria are met. The actual number of shares earned could range from 0 to 200% of the number of Performance Shares granted. Fair market value on date of grant is $20.94 per share. There is no fixed expiration date.